Levofloxacin pharmacokinetics in saliva as measured by a mobile microvolume UV spectrophotometer among people treated for rifampicin-resistant TB in Tanzania
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkab057
Abstract: Abstract Background Early detection and correction of low fluoroquinolone exposure may improve treatment of MDR-TB. Objectives To explore a recently developed portable, battery-powered, UV spectrophotometer for measuring levofloxacin in saliva of people treated for MDR-TB.… read more here.
Keywords: saliva; auc0; levofloxacin; serum ... See more keywords
Sexual dysfunction in people treated with long-acting injectable antipsychotics in monotherapy or polypharmacy: a naturalistic study.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of mental health nursing"
DOI: 10.1111/inm.12973
Abstract: Sexual dysfunction, psychosis, and antipsychotics are known to be related, but the precise association between them is still unknown. Most evidence about the prevalence of sexual dysfunction in people treated with antipsychotic drugs comes from… read more here.
Keywords: treated long; people treated; acting injectable; dysfunction ... See more keywords
The relationship between outpatient service use and emergency department visits among people treated for mental and substance use disorders: analysis of population-based administrative data in British Columbia, Canada
Sign Up to like & getrecommendations! Published in 2022 at "BMC Health Services Research"
DOI: 10.1186/s12913-022-07759-z
Abstract: Background Research findings on the association between outpatient service use and emergency department (ED) visits for mental and substance use disorders (MSUDs) are mixed and may differ by disorder type. Methods We used population-based linked… read more here.
Keywords: among people; service use; outpatient service; people treated ... See more keywords
Plain language summary of outcomes in people treated for lung squamous cell cancer with afatinib after receiving pembrolizumab with chemotherapy.
Sign Up to like & getrecommendations! Published in 2022 at "Future oncology"
DOI: 10.2217/fon-2022-0411
Abstract: WHAT IS THIS SUMMARY ABOUT? Afatinib can be used as a treatment for people with metastatic squamous cell carcinoma (shortened to SqCC) of the lung, after they have been treated with chemotherapy. Nowadays, people with… read more here.
Keywords: people treated; side effects; afatinib; treatment ... See more keywords